# Uniphos Enterprises share price today (Uniphos Enterprises Ltd, NSE: UNIENTER)

> Uniphos Enterprises share price today: ₹87.90 at the NSE close on 30 October 2026, down 40.7% in a year. Uniphos Enterprises (NSE: UNIENTER) trades at a P/E of 29.3 and has closed between ₹80.00 and ₹153.61 over the past 52 weeks. > Uniphos Enterprises Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. UNIENTER · Trading · data as of 30 October 2026. Page: https://www.sectoralpha.in/stocks/uniphos-enterprises-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: ₹87.90 (−40.7% in a year)
- P/E: 29.3× (higher than 51% of the last 11 years)
- Revenue (Jun 2026): ₹0.0 Cr
- Profit (Jun 2026): −₹1.2 Cr
- ROCE: 1%, FY26

The main question: yearly earnings per share moved +7,350.0% while the share price moved −40.7%. ## What is the Uniphos Enterprises share price today? Uniphos Enterprises Ltd's share price was ₹87.90 at the close on 30 October 2026. It has been falling for 56 weeks. That is 17.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹80 and ₹154, and at that close it sat 11% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 19 weeks running. Over the last 11 years the share price moved +170% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 10 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Uniphos Enterprises this quarter? Two changes stood out: profit fell in the June 2026 quarter and revenue down on a year earlier for 4 quarters in a row. 1. Profit fell in the June 2026 quarter Profit was ₹-1 crore, -60.8% on a year earlier (₹-1 crore), after 3 quarters of growth. 2. Revenue down on a year earlier for 4 quarters in a row In the June 2026 quarter revenue was ₹0 crore, -100% on a year earlier. ## What dividend does Uniphos Enterprises pay? Uniphos Enterprises paid ₹3.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 3.98% at the ₹87.90 close on 30 October 2026. The last was a dividend of ₹3.50 a share, ex-date 17 July 2026. ### Uniphos Enterprises dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 17 Jul 2026 | ₹3.50 | Dividend |
| 29 Aug 2025 | ₹0.50 | Dividend |
| 6 Sep 2024 | ₹5.70 | Dividend |
| 11 Aug 2023 | ₹6.50 | Dividend |
| 4 Aug 2022 | ₹5.65 | Dividend |
| 29 Jul 2021 | ₹3.40 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Uniphos Enterprises Ltd paid out 118% of its profit as dividends in FY26, and it paid a dividend in 6 of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What are Uniphos Enterprises' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Uniphos Enterprises reported revenue of ₹0.00 crore, down 100.0% from ₹5.86 crore a year earlier, and a loss of ₹1.19 crore. ### Uniphos Enterprises results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹0.00 crore | ₹5.86 crore | −100.0% |
| Profit | loss of ₹1.19 crore | loss of ₹0.74 crore | n/a |
| Earnings per share | ₹−0.17 | ₹−0.11 | n/a |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Uniphos Enterprises share price history? Uniphos Enterprises closed at ₹87.90 on 30 October 2026, down 40.7% from ₹148.21 a year earlier (31 October 2025) and down 26.3% over five years. Its highest weekly close since March 2016 was ₹185.70 on 6 September 2024. ### Uniphos Enterprises share price: then and now

| When | Close | Change to 30 Oct 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹80.00 | +9.9% |
| 1 month ago · 1 Oct 2026 | ₹86.73 | +1.3% |
| 6 months ago · 30 Apr 2026 | ₹107.30 | −18.1% |
| 1 year ago · 31 Oct 2025 | ₹148.21 | −40.7% |
| 3 years ago · 27 Oct 2023 | ₹158.15 | −44.4% |
| 5 years ago · 29 Oct 2021 | ₹119.20 | −26.3% |
| 10 years ago · 30 Oct 2016 | ₹68.05 | +29.2% |
| Earliest and lowest weekly close in our records · 11 Mar 2016 | ₹32.55 | +170.0% |
| Highest weekly close since March 2016 · 6 Sep 2024 | ₹185.70 | −52.7% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹153.61 | −42.8% |
| 52-week low (weekly close) · 23 Oct 2026 | ₹80.00 | +9.9% |

Weekly closing prices. Each change is the move from that price to the 30 Oct 2026 close. A day's intraday high or low can go beyond these weekly closes. (562 weekly closes from 11 March 2016 to 30 October 2026.)

## What is the latest news on Uniphos Enterprises? 30 Oct 2026: Uniphos Enterprises closed at ₹87.90, up 9.9% on the week and up 1.3% on the month. 17 Jul 2026: ex-date for a dividend of ₹3.50 a share. ### Earlier

- Results for April to June 2026: Revenue down 100.0% on a year earlier. ## Which stock lists is Uniphos Enterprises on? Uniphos Enterprises is on 2 of our India lists: Dividend stocks and Penny stocks. - [Dividend stocks Regular dividend yield (%): 4.04](https://www.sectoralpha.in/dividend-stocks-india)
- [Penny stocks](https://www.sectoralpha.in/penny-stocks-india)

## Is Uniphos Enterprises profitable? Uniphos Enterprises Ltd posted a net loss of ₹1.2 Cr in the Jun 2026 quarter. Full-year FY26 profit was ₹21.0 Cr. Over 10 years profit has grown 5.8% a year on average. The same quarter a year earlier lost ₹0.7 Cr. 9 of the last 12 reported quarters were loss-making. ## How much revenue does Uniphos Enterprises make, and is it growing? Uniphos Enterprises Ltd reported ₹0.0 Cr of revenue in the Jun 2026 quarter, −100.0% on the same quarter a year earlier. The last full year, FY26, came in at ₹32.0 Cr. The last four reported quarters add to ₹26.1 Cr. A growth rate over several years is not shown, because there are too few years of figures to work one out properly. FY26 revenue was ₹32.0 Cr, −71.4% on the year before. Is growth speeding up? Revenue over the last 12 months grew −77.1%, against −30.2% a year over the last 8 quarters (rolling over). ## How much of every ₹100 of sales does Uniphos Enterprises keep? We do not have a clean operating margin for Uniphos Enterprises Ltd. Its accounts do not report the operating-profit line this section uses, which is common for lenders and holding companies. The other sections show what its filings do report. Why the margin moved: operating margin changed −1.6 percentage points on the year while gross margin changed −0.1 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Uniphos Enterprises' profit turning into cash? Over the last 3 years Uniphos Enterprises Ltd's operations used more cash than they brought in, so cash conversion was −7%, a gap worth watching. In FY26 its operations used ₹3.0 Cr of cash, against ₹21.0 Cr of profit. After ₹1.0 Cr of spending on assets, free cash was −₹4.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Uniphos Enterprises' cash go? Uniphos Enterprises Ltd's customer, stock and supplier day counts are not a useful reading on sales this small (₹32.0 Cr in FY26), so no cash-cycle chart is drawn and this section looks at its spending on assets instead. It spent ₹1.0 Cr on assets over the last 3 years. Averaged over those years that is 1.0% of FY26 revenue a year. Spending on assets: ₹1.0 Cr over the last 3 years, against ₹3.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Uniphos Enterprises' P/E ratio, and how does it compare with its own history? Uniphos Enterprises Ltd's P/E is 29.3×, in the middle of its own history: higher than 51% of past readings. Its usual P/E (the middle reading) is 29.2×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +7,350.0% while the price moved −40.7%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −5.9% a year; about −8.7% a year came from earnings growth and about +2.8 percentage points from the multiple (the market paying more); over 10 years the price moved +2.6% a year; about +6.2% a year came from earnings growth and about −3.6 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Uniphos Enterprises business getting better or worse? Uniphos Enterprises Ltd's business is turning around. Profit growth has swung from −99.3% at its low to +7570.4%, improving for 3 quarters in a row, with ROCE steady at 0.0%. This is based on 9 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. ## How much does Uniphos Enterprises earn on its capital? Uniphos Enterprises Ltd earned a ROCE of 1% in FY26. That is up from a low of 0% in FY25. Its return on capital used (ROIC) is left out: on sales this small it reads 0%, a number that says nothing useful about the business. It comes from a 65.6% net margin and 0.01× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 65.6% net margin × 0.01× asset turnover × 1.07× leverage (assets divided by equity) ≈ 0.7% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. ## Does Uniphos Enterprises have too much debt? Uniphos Enterprises Ltd had ₹0.0 Cr of borrowings against ₹2,447 Cr of equity in FY26, so its debt is 0.00× its equity. Over 5 years borrowings went from ₹0.0 Cr to ₹0.0 Cr. Over the last 3 of those years it spent ₹1.0 Cr on assets. The spending on assets is being paid for from cash, not new debt. ## What is the Uniphos Enterprises shareholding pattern? No group of Uniphos Enterprises Ltd's owners changed its stake by a full percentage point over the last two years. Promoters moved +0.0 points over the same period, to 73.8%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: +0.1 points over 8 quarters, to 15.8%; Promoters: +0.0 points over 8 quarters, to 73.8%. ## How far is Uniphos Enterprises from balance-sheet trouble? For Uniphos Enterprises Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Uniphos Enterprises rank in its industry? 35.7 out of 100, rank 37 of 63 in Trading, with 59% of the evidence available. Uniphos Enterprises Ltd scores 35.7 out of 100 against the 63 companies it is compared with in Trading, ranking 37. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 13.2 + 4 + 10.3 + 8.2 = 35.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Uniphos Enterprises compared with? Uniphos Enterprises ranks 37 of 63 Trading companies on the 4-Factor Sector Score, with 35.7 out of 100. 1. [Mangalam Global Enterprise Ltd](https://www.sectoralpha.in/stocks/mangalam-global-enterprise-ltd) MGEL · turning · Most evidence points up · 93% evidence 70.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.5/35 · Revenue 44.2% · Profit 8.2% · Operating margin change 0.7 points · 100% evidence Capital efficiency 14.6/25 · ROCE 17% · Operating margin 2.3% · 100% evidence Valuation 15.8/20 · P/E 14.6× · PEG 0.31 · 65% evidence Relative strength 17.2/20 · Lead over its industry 12.9% · Lead over NIFTY 500 25.7% · 1 year 18.7% · 100% evidence · 5 of 12 weeks ahead Exact sum: 22.5 + 14.6 + 15.8 + 17.2 = 70.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Shankara Buildpro Ltd](https://www.sectoralpha.in/stocks/shankara-buildpro-ltd) BUILDPRO · quiet · Too little evidence to rank firmly · 59% evidence 64.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/43.75 · Revenue 26.3% · Profit 41.9% · Operating margin change -0.2 points · 88% evidence Capital efficiency 21.5/31.25 · ROCE 39% · Operating margin 3.2% · 100% evidence Valuation 13.4/25 · P/E 16× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 30 + 21.5 + 13.4 = 64.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 3. [Ivalue Infosolutions Ltd](https://www.sectoralpha.in/stocks/ivalue-infosolutions-ltd) IVALUE · quiet · Evidence leans up · 74% evidence 64.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 5.4% · Profit 22.1% · Operating margin change 5.6 points · 88% evidence Capital efficiency 19.8/25 · ROCE 25.4% · Operating margin 10% · 100% evidence Valuation 15.7/20 · P/E 10× · PEG 0.43 · 65% evidence Relative strength 8.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -18.6% · 1 year -31.1% · 25% evidence · 3 of 12 weeks ahead Exact sum: 20.7 + 19.8 + 15.7 + 8.1 = 64.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Maxgrow India Ltd](https://www.sectoralpha.in/stocks/maxgrow-india-ltd) Too little evidence to rank firmly · 53% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.9/35 · Revenue 100% · Profit 100% · Operating margin change 0.8 points · 62% evidence Capital efficiency 16.4/25 · ROCE 23.5% · Operating margin 2.7% · 95% evidence Valuation 11.5/20 · P/E 1.2× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 136% · 1 year n/a · 25% evidence Exact sum: 23.9 + 16.4 + 11.5 + 12.4 = 64.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [Nupur Recyclers Ltd](https://www.sectoralpha.in/stocks/nupur-recyclers-ltd) NRL · leader · Evidence leans up · 78% evidence 63.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.0/35 · Revenue 40.6% · Profit 29.8% · Operating margin change 3.6 points · 83% evidence Capital efficiency 15.3/25 · ROCE 15.1% · Operating margin 11.6% · 76% evidence Valuation 7.6/20 · P/E 64.4× · PEG n/a · 50% evidence Relative strength 19.9/20 · Lead over its industry 86.1% · Lead over NIFTY 500 100.5% · 1 year 134.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 21 + 15.3 + 7.6 + 19.9 = 63.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Arisinfra Solutions Ltd](https://www.sectoralpha.in/stocks/arisinfra-solutions-ltd) ARIS · breaking out · Too little evidence to rank firmly · 56% evidence 61.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.5/35 · Revenue 45.3% · Profit 100% · Operating margin change 2 points · 83% evidence Capital efficiency 13.5/25 · ROCE 15.6% · Operating margin 11% · 76% evidence Valuation 10.7/20 · P/E 17.2× · PEG n/a · 15% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 16.6% · 1 year -14.9% · 25% evidence · 11 of 12 weeks ahead Exact sum: 26.5 + 13.5 + 10.7 + 10.9 = 61.6 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [Bhatia Communications & Retail (India) Ltd](https://www.sectoralpha.in/stocks/bhatia-communications-retail-indialtd) Evidence leans up · 68% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.7/35 · Revenue 49% · Profit 45.5% · Operating margin change 0.3 points · 83% evidence Capital efficiency 18.4/25 · ROCE 21.3% · Operating margin 5.3% · 95% evidence Valuation 9.2/20 · P/E 22.8× · PEG n/a · 50% evidence Relative strength 11.5/20 · Lead over its industry n/a · Lead over NIFTY 500 30.1% · 1 year n/a · 25% evidence Exact sum: 21.7 + 18.4 + 9.2 + 11.5 = 60.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [DC Infotech & Communication Ltd](https://www.sectoralpha.in/stocks/dc-infotech-communication-ltd) DCI · breaking out · Evidence leans up · 81% evidence 60.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue 29.1% · Profit 41.9% · Operating margin change 0.4 points · 88% evidence Capital efficiency 16.5/25 · ROCE 23% · Operating margin 4.8% · 100% evidence Valuation 13.4/20 · P/E 24.6× · PEG 0.82 · 100% evidence Relative strength 11.1/20 · Lead over its industry n/a · Lead over NIFTY 500 20.1% · 1 year n/a · 25% evidence · 6 of 6 weeks ahead Exact sum: 19.3 + 16.5 + 13.4 + 11.1 = 60.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [SG Mart Ltd](https://www.sectoralpha.in/stocks/sg-mart-ltd) SGMART · leader · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 9.7% · Profit 26.7% · Operating margin change 3 points · 100% evidence Capital efficiency 11.6/25 · ROCE 10.2% · Operating margin 4.6% · 100% evidence Valuation 7.9/20 · P/E 71.1× · PEG 1.81 · 65% evidence Relative strength 18.3/20 · Lead over its industry 47.1% · Lead over NIFTY 500 60.5% · 1 year 146.8% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.3 + 11.6 + 7.9 + 18.3 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Tembo Global Industries Ltd](https://www.sectoralpha.in/stocks/tembo-global-industries-ltd) TEMBO · losing its lead · Evidence leans up · 71% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.6/35 · Revenue 34% · Profit 55.7% · Operating margin change 5 points · 83% evidence Capital efficiency 19.6/25 · ROCE 22.8% · Operating margin 16% · 76% evidence Valuation 11.2/20 · P/E 9.3× · PEG n/a · 15% evidence Relative strength 7.0/20 · Lead over its industry -19.2% · Lead over NIFTY 500 -8.7% · 1 year -20.8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.6 + 19.6 + 11.2 + 7 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Rashi Peripherals Ltd](https://www.sectoralpha.in/stocks/rashi-peripherals-ltd) RPTECH · losing its lead · Evidence leans up · 78% evidence 59.3 out of 100 Growth Capital Valuation Relative
12. [Sudarshan Pharma Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-pharma-industries-ltd) SUDARSHAN · turning · Evidence leans up · 85% evidence 58.7 out of 100 Growth Capital Valuation Relative
13. [Singer India Ltd](https://www.sectoralpha.in/stocks/singer-india-ltd) SINGERIND · Evidence leans up · 61% evidence 58.0 out of 100 Growth Capital Valuation Relative
14. [Euro Pratik Sales Ltd](https://www.sectoralpha.in/stocks/euro-pratik-sales-ltd) EUROPRATIK · quiet · Evidence leans up · 64% evidence 57.5 out of 100 Growth Capital Valuation Relative
15. [Pramara Promotions Ltd](https://www.sectoralpha.in/stocks/pramara-promotions-ltd) PRAMARA · Too little evidence to rank firmly · 52% evidence 54.6 out of 100 Growth Capital Valuation Relative
16. [State Trading Corporation of India Ltd](https://www.sectoralpha.in/stocks/state-trading-corporation-of-india-ltd) STCINDIA · quiet · Too little evidence to rank firmly · 57% evidence 53.4 out of 100 Growth Capital Valuation Relative
17. [Patel Retail Ltd](https://www.sectoralpha.in/stocks/patel-retail-ltd) PATELRMART · turning · Evidence leans up · 64% evidence 53.2 out of 100 Growth Capital Valuation Relative
18. [Yogi Ltd](https://www.sectoralpha.in/stocks/yogi-ltd) YOGI · quiet · Evidence leans up · 64% evidence 51.2 out of 100 Growth Capital Valuation Relative
19. [Transchem Ltd](https://www.sectoralpha.in/stocks/transchem-ltd) TRANSCHEM · Too little evidence to rank firmly · 52% evidence 51.0 out of 100 Growth Capital Valuation Relative
20. [Prostarm Info Systems Ltd](https://www.sectoralpha.in/stocks/prostarm-info-systems-ltd) PROSTARM · breaking out · Evidence leans up · 64% evidence 50.8 out of 100 Growth Capital Valuation Relative
21. [Dhunseri Ventures Ltd](https://www.sectoralpha.in/stocks/dhunseri-ventures-ltd) DVL · breaking out · Evidence leans up · 78% evidence 50.6 out of 100 Growth Capital Valuation Relative
22. Bizotic Commercial Ltd losing its lead · Evidence leans up · 63% evidence 50.5 out of 100 Growth Capital Valuation Relative
23. BMW Ventures Ltd BMW · Too little evidence to rank firmly · 51% evidence 50.2 out of 100 Growth Capital Valuation Relative
24. [Cropster Agro Ltd](https://www.sectoralpha.in/stocks/cropster-agro-ltd) quiet · Evidence leans down · 65% evidence 49.1 out of 100 Growth Capital Valuation Relative
25. [MMTC Ltd](https://www.sectoralpha.in/stocks/mmtc-ltd) MMTC · quiet · Evidence leans down · 92% evidence 47.2 out of 100 Growth Capital Valuation Relative
26. [Shiv Aum Steels Ltd](https://www.sectoralpha.in/stocks/shiv-aum-steels-ltd) SHIVAUM · breaking out · Evidence leans down · 63% evidence 46.8 out of 100 Growth Capital Valuation Relative
27. [Blue Pearl Agriventures Ltd](https://www.sectoralpha.in/stocks/blue-pearl-agriventures-ltd) BPAGRI · Too little evidence to rank firmly · 51% evidence 43.8 out of 100 Growth Capital Valuation Relative
28. [Lloyds Enterprises Ltd](https://www.sectoralpha.in/stocks/lloyds-enterprises-ltd) LLOYDSENT · quiet · Evidence leans down · 71% evidence 43.1 out of 100 Growth Capital Valuation Relative
29. [Hexa Tradex Ltd](https://www.sectoralpha.in/stocks/hexa-tradex-ltd) HEXATRADEX · breaking out · Evidence leans down · 64% evidence 39.9 out of 100 Growth Capital Valuation Relative
30. [Shanti Overseas (India) Ltd](https://www.sectoralpha.in/stocks/shanti-overseas-indialtd) SHANTI · Evidence leans down · 61% evidence 39.3 out of 100 Growth Capital Valuation Relative
31. [Riddhi Siddhi Gluco Biols Ltd](https://www.sectoralpha.in/stocks/riddhi-siddhi-gluco-biols-ltd) turning · Evidence leans down · 83% evidence 38.9 out of 100 Growth Capital Valuation Relative
32. [Hardwyn India Ltd](https://www.sectoralpha.in/stocks/hardwyn-india-ltd) HARDWYN · basing · Evidence leans down · 86% evidence 38.8 out of 100 Growth Capital Valuation Relative
33. [Adani Enterprises Ltd](https://www.sectoralpha.in/stocks/adani-enterprises-ltd) ADANIENT · quiet · Evidence leans down · 93% evidence 38.1 out of 100 Growth Capital Valuation Relative
34. [PTC India Ltd](https://www.sectoralpha.in/stocks/ptc-india-ltd) PTC · quiet · Evidence leans down · 78% evidence 37.4 out of 100 Growth Capital Valuation Relative
35. [Le Merite Exports Ltd](https://www.sectoralpha.in/stocks/le-merite-exports-ltd) LEMERITE · Too little evidence to rank firmly · 59% evidence 36.8 out of 100 Growth Capital Valuation Relative
36. [Fabtech Technologies Ltd](https://www.sectoralpha.in/stocks/fabtech-technologies-ltd) FABTECH · quiet · Evidence leans down · 68% evidence 36.7 out of 100 Growth Capital Valuation Relative
37. Uniphos Enterprises Ltd this page UNIENTER · turning · Too little evidence to rank firmly · 59% evidence 35.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.2/35 · Revenue -77.1% · Profit 100% · Operating margin change -0.9 points · 65% evidence Capital efficiency 4.0/25 · ROCE 0.8% · Operating margin n/a · 84% evidence Valuation 10.3/20 · P/E 29.3× · PEG n/a · 50% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -16.5% · 1 year -40.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 13.2 + 4 + 10.3 + 8.2 = 35.7 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 38. Manbro Industries Ltd Too little evidence to rank firmly · 57% evidence 35.3 out of 100 Growth Capital Valuation Relative
39. Shah Foods Ltd quiet · Too little evidence to rank firmly · 53% evidence 35.3 out of 100 Growth Capital Valuation Relative
40. [BN Agrochem Ltd](https://www.sectoralpha.in/stocks/bn-agrochem-ltd) BNAGROCHEM · quiet · Most evidence points down · 64% evidence 34.1 out of 100 Growth Capital Valuation Relative
41. [Neueon Corporation Ltd](https://www.sectoralpha.in/stocks/neueon-corporation-ltd) NEUEON · quiet · Too little evidence to rank firmly · 56% evidence 33.3 out of 100 Growth Capital Valuation Relative
42. [Kothari Industrial Corporation Ltd](https://www.sectoralpha.in/stocks/kothari-industrial-corporation-ltd) KOTIC · quiet · Too little evidence to rank firmly · 53% evidence 32.9 out of 100 Growth Capital Valuation Relative
43. [Oswal Agro Mills Ltd](https://www.sectoralpha.in/stocks/oswal-agro-mills-ltd) OSWALAGRO · Too little evidence to rank firmly · 52% evidence 28.6 out of 100 Growth Capital Valuation Relative
44. [Susan Electricals India Ltd](https://www.sectoralpha.in/stocks/susan-electricals-india-ltd) quiet · Too little evidence to rank firmly · 36% evidence 61.2 out of 100 Growth Capital Valuation Relative
45. [Magnus Steel & Infra Ltd](https://www.sectoralpha.in/stocks/magnus-steel-infra-ltd) Too little evidence to rank firmly · 40% evidence 61.1 out of 100 Growth Capital Valuation Relative
46. [Vision Infra Equipment Solutions Ltd](https://www.sectoralpha.in/stocks/vision-infra-equipment-solutions-ltd) VIESL · breaking out · Too little evidence to rank firmly · 47% evidence 58.5 out of 100 Growth Capital Valuation Relative
47. [Q-Line Biotech Ltd](https://www.sectoralpha.in/stocks/q-line-biotech-ltd) QLINE · losing its lead · Too little evidence to rank firmly · 21% evidence 57.8 out of 100 Growth Capital Valuation Relative
48. Aayush Art and Bullion Ltd breaking out · Too little evidence to rank firmly · 48% evidence 57.1 out of 100 Growth Capital Valuation Relative
49. [HP Telecom India Ltd](https://www.sectoralpha.in/stocks/hp-telecom-india-ltd) HPTL · Too little evidence to rank firmly · 32% evidence 57.1 out of 100 Growth Capital Valuation Relative
50. [SK Minerals & Additives Ltd](https://www.sectoralpha.in/stocks/sk-minerals-additives-ltd) quiet · Too little evidence to rank firmly · 43% evidence 55.9 out of 100 Growth Capital Valuation Relative
51. [Aptus Pharma Ltd](https://www.sectoralpha.in/stocks/aptus-pharma-ltd) Too little evidence to rank firmly · 41% evidence 55.6 out of 100 Growth Capital Valuation Relative
52. [Mardia Samyoung Capillary Tubes Company Ltd](https://www.sectoralpha.in/stocks/mardia-samyoung-capillary-tubes-company-ltd) MSCTC · Too little evidence to rank firmly · 26% evidence 55.3 out of 100 Growth Capital Valuation Relative
53. [Proventus Agrocom Ltd](https://www.sectoralpha.in/stocks/proventus-agrocom-ltd) PROV · breaking out · Too little evidence to rank firmly · 39% evidence 54.1 out of 100 Growth Capital Valuation Relative
54. [Pervasive Commodities Ltd](https://www.sectoralpha.in/stocks/pervasive-commodities-ltd) breaking out · Too little evidence to rank firmly · 48% evidence 51.8 out of 100 Growth Capital Valuation Relative
55. [Monika Alcobev Ltd](https://www.sectoralpha.in/stocks/monika-alcobev-ltd) MONIKA · Too little evidence to rank firmly · 27% evidence 49.9 out of 100 Growth Capital Valuation Relative
56. [Onix Solar Energy Ltd](https://www.sectoralpha.in/stocks/onix-solar-energy-ltd) ONIXSOLAR · quiet · Too little evidence to rank firmly · 47% evidence 45.8 out of 100 Growth Capital Valuation Relative
57. Arvaya Healthcare Ltd ARVAYA · quiet · Too little evidence to rank firmly · 46% evidence 45.4 out of 100 Growth Capital Valuation Relative
58. [A-1 Ltd](https://www.sectoralpha.in/stocks/a-1-ltd) A1L · Too little evidence to rank firmly · 33% evidence 45.3 out of 100 Growth Capital Valuation Relative
59. [Satani Bearings Ltd](https://www.sectoralpha.in/stocks/satani-bearings-ltd) breaking out · Too little evidence to rank firmly · 42% evidence 42.9 out of 100 Growth Capital Valuation Relative
60. [Keto Motors Ltd](https://www.sectoralpha.in/stocks/keto-motors-ltd) quiet · Too little evidence to rank firmly · 42% evidence 40.9 out of 100 Growth Capital Valuation Relative
61. [Aerpace Industries Ltd](https://www.sectoralpha.in/stocks/aerpace-industries-ltd) breaking out · Too little evidence to rank firmly · 36% evidence 37.9 out of 100 Growth Capital Valuation Relative
62. [Prabhatam Infra Venture Ltd](https://www.sectoralpha.in/stocks/prabhatam-infra-venture-ltd) PRABHATAM · Too little evidence to rank firmly · 22% evidence 36.8 out of 100 Growth Capital Valuation Relative
63. [RRP Semiconductor Ltd](https://www.sectoralpha.in/stocks/rrp-semiconductor-ltd) RRP · Too little evidence to rank firmly · 42% evidence 34.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Trading](https://www.sectoralpha.in/sectors/trading), all 63 compared on one page. ## Which companies are close to Uniphos Enterprises in size? Uniphos Enterprises is the 38th largest of 59 Trading companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Neueon Corporation, Hardwyn India and HP Telecom India. Just below it: State Trading Corporation of India, Prabhatam Infra Venture and Satani Bearings. ### Trading companies close in size

1. [Neueon Corporation Ltd](https://www.sectoralpha.in/stocks/neueon-corporation-ltd) ₹615 crore
2. [Hardwyn India Ltd](https://www.sectoralpha.in/stocks/hardwyn-india-ltd) ₹610 crore
3. [HP Telecom India Ltd](https://www.sectoralpha.in/stocks/hp-telecom-india-ltd) ₹595 crore
4. Uniphos Enterprises Ltd ₹594 crore
5. [State Trading Corporation of India Ltd](https://www.sectoralpha.in/stocks/state-trading-corporation-of-india-ltd) ₹592 crore
6. [Prabhatam Infra Venture Ltd](https://www.sectoralpha.in/stocks/prabhatam-infra-venture-ltd) ₹585 crore
7. [Satani Bearings Ltd](https://www.sectoralpha.in/stocks/satani-bearings-ltd) ₹582 crore

[All 59 Trading companies, largest first](https://www.sectoralpha.in/sectors/trading#all-companies)

### Companies close in size in other industries

1. [Aditya Birla Money Ltd](https://www.sectoralpha.in/stocks/aditya-birla-money-ltd) ₹594 crore · Finance - Capital Markets
2. [Jaiprakash Associates Ltd](https://www.sectoralpha.in/stocks/jaiprakash-associates-ltd) ₹594 crore · Construction & Contracting
3. Uniphos Enterprises Ltd ₹594 crore
4. [Denta Water & Infra Solutions Ltd](https://www.sectoralpha.in/stocks/denta-water-infra-solutions-ltd) ₹592 crore · Construction - Civil/Turnkey
5. [Kanpur Plastipack Ltd](https://www.sectoralpha.in/stocks/kanpur-plastipack-ltd) ₹592 crore · Packaging - Polysacks

## What else do people ask about Uniphos Enterprises? ### What were Uniphos Enterprises's latest quarterly results? Uniphos Enterprises Ltd reported revenue of ₹0.0 Cr and a net loss of ₹1.2 Cr for the Jun 2026 quarter. Earnings per share were −₹0.17 (as of 30 October 2026). ### What is Uniphos Enterprises's market cap? Uniphos Enterprises Ltd's market capitalisation is ₹594 Cr at a share price of ₹87.90. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 30 October 2026). ### How is Uniphos Enterprises performing? Uniphos Enterprises Ltd's share price has been falling for 56 weeks. Over the past 13 weeks it has done worse than the NIFTY 500, for 19 weeks running. This describes what the data did, not a rating (as of 30 October 2026). ### Will Uniphos Enterprises's share price go up? This page does not forecast Uniphos Enterprises Ltd's share price. What it shows instead: the share price is ₹87.90, and it has been falling for 56 weeks. Its P/E of 29.3× is higher than 51% of its own last 11 years (as of 30 October 2026). ### Who owns Uniphos Enterprises? Promoters own 73.8% of Uniphos Enterprises Ltd, foreign institutions 15.8%, domestic institutions, and the public 10.4% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 30 October 2026). ### Where is Uniphos Enterprises in its business cycle? Uniphos Enterprises Ltd's FY26 operating margin was −12.0%, against a 9-year range of −987.0% to −3.4%: the middle of its own range, neither a peak nor a low. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 30 October 2026). ### What could break the Uniphos Enterprises story? The main question: yearly earnings per share moved +7,350.0% while the share price moved −40.7%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 30 October 2026). ### Is Uniphos Enterprises a stock worth studying right now? What the numbers show: Uniphos Enterprises Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 30 October 2026). ## Lists

- Dividend stocks: https://www.sectoralpha.in/dividend-stocks-india
- Penny stocks: https://www.sectoralpha.in/penny-stocks-india

This is research, not advice. We’re not SEBI-registered.